Patents by Inventor Ulrich Hengst

Ulrich Hengst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210246180
    Abstract: The invention relates to expressing proteins in the axons of mammalian neurons. The invention provides nucleic acids that can be used to express a selected polypeptide in neuronal axons, viruses that can be used deliver nucleic acids of the invention into neuronal axons, as well as methods for doing so. Thus, the invention provides pharmaceutical compositions comprising viruses of the invention, as well as their use in methods of treating injured axons or conditions associated with aberrant axon growth or function.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 12, 2021
    Inventors: Samie R. Jaffrey, Ulrich Hengst
  • Patent number: 10941186
    Abstract: The invention relates to expressing proteins in the axons of mammalian neurons. The invention provides nucleic acids that can be used to express a selected polypeptide in neuronal axons, viruses that can be used deliver nucleic acids of the invention into neuronal axons, as well as methods for doing so. Thus, the invention provides pharmaceutical compositions comprising viruses of the invention, as well as their use in methods of treating injured axons or conditions associated with aberrant axon growth or function.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: March 9, 2021
    Assignee: Cornell University
    Inventors: Samie R. Jaffrey, Ulrich Hengst
  • Publication number: 20100330038
    Abstract: The invention relates to expressing proteins in the axons of mammalian polypeptide in neuronal axons, viruses that can be used deliver nucleic acids of the invention into neuronal axons, as well as methods for doing so. Thus, the invention provides pharmaceutical compositions comprising viruses of the invention, as well as their use in methods of treating injured axons or conditions associated with aberrant axon growth or function.
    Type: Application
    Filed: July 8, 2010
    Publication date: December 30, 2010
    Applicant: Cornell University
    Inventors: Samie R. Jaffrey, Ulrich Hengst
  • Publication number: 20060177432
    Abstract: The invention discloses a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.
    Type: Application
    Filed: December 19, 2005
    Publication date: August 10, 2006
    Inventors: Hugo Albrecht, Ulrich Hengst, Denis Monard
  • Patent number: 7029877
    Abstract: There is provided a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: April 18, 2006
    Assignee: Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Instittue for Biomedical Research
    Inventors: Hugo Albrecht, Ulrich Hengst, Denis Monard
  • Publication number: 20050037009
    Abstract: There is provided a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.
    Type: Application
    Filed: August 30, 2001
    Publication date: February 17, 2005
    Inventors: Hugo Albrecht, Ulrich Hengst, Denis Monard